Press Releases

Mallinckrodt Initiates Retrospective Study of the Use of Inhaled...

Mallinckrodt plc, a global biopharmaceutical company, announced initiation of a retrospective chart review study, titled "Nitric Oxide Treatment In COVID-19 Evaluation (NOTICE)" to collect real-world...

InSilicoTrials presents a suite of highly innovative products that...

The global drug discovery market is growing rapidly: it is expected that it will reach 71 billion dollars by 2025, while in 2016 it was...

Altimmune Adds Lonza as a Manufacturing Partner for Supply...

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it entered into an agreement with Lonza for the manufacturing of AdCOVID™, Altimmune’s next-generation, single-dose intranasal vaccine...

Biocair and Roylance Pharma partner to provide end-to-end logistics...

Biocair, a global logistics company dedicated to the life sciences, has partnered with Roylance Pharma to deliver fully integrated transportation and storage services for temperature-controlled...

Lilly’s neutralizing antibody bamlanivimab receives FDA emergency use authorization...

The U.S. FDA granted Emergency Use Authorization for Eli Lilly and Company's investigational neutralizing antibody bamlanivimab 700 mg. Bamlanivimab is authorized for the treatment of...

Transcenta and Merck Announce a Strategic Collaboration at CIIE...

Transcenta, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, and Merck, a leading science and technology company, have...

Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved...

Pfizer Inc. and BioNTech SE announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read